We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$40.7B
AUM Growth
+$557M
(+1.4%)
Cap. Flow
+$599M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
20.37%
Holding
791
New
88
Increased
233
Reduced
320
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$977M |
| 2 |
Lockheed Martin
LMT
|
+$187M |
| 3 |
Kimberly-Clark
KMB
|
+$149M |
| 4 |
CELG
Celgene Corp
CELG
|
+$142M |
| 5 |
Under Armour Class C
UA
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$781M |
| 2 |
RTN
Raytheon Company
RTN
|
+$186M |
| 3 |
Costco
COST
|
+$133M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.26% |
| 2 | Technology | 16.18% |
| 3 | Financials | 12.32% |
| 4 | Consumer Discretionary | 11.38% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Iron Mountain
IRM
$36.4B
| $9.54M | 0.02% |
294,552
+21,800
| +8% | +$685K |
|
527
Incyte
INCY
$24.2B
| $9.35M | 0.02% |
125,952
-2,000
| -2% | -$162K |
|
528
Syndax Pharmaceuticals
SNDX
$1.69B
| $9.34M | 0.02% |
1,250,000
-225,000
| -15% | -$2.05M |
|
529
Milestone Pharmaceuticals
MIST
$138M
| $9.32M | 0.02% |
500,000
+260,000
| +108% | +$5.12M |
|
|
TVRD
530
Tvardi Therapeutics
TVRD
$19.7M
| $9.27M | 0.02% |
+14,083
| New | +$11.7M |
|
|
UROV
531
DELISTED
Urovant Sciences Ltd.
UROV
| $9.23M | 0.02% |
975,000
-25,000
| -3% | -$217K |
|
532
Vornado Realty Trust
VNO
$7.41B
| $9.22M | 0.02% |
144,821
-63,738
| -31% | -$4.01M |
|
533
Waters Corp
WAT
$37B
| $9.21M | 0.02% |
41,278
-45,778
| -53% | -$9.88M |
|
534
BorgWarner
BWA
$13.1B
| $9.16M | 0.02% |
283,659
+184,827
| +187% | +$5.95M |
|
|
STSA
535
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $9.16M | 0.02% |
+610,000
| New | +$9.46M |
|
536
Timken Company
TKR
$9.56B
| $9.13M | 0.02% |
209,930
-86,744
| -29% | -$3.83M |
|
|
VAPO
537
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $9.13M | 0.02% |
120,486
+6,921
| +6% | +$804K |
|
|
NLSN
538
DELISTED
Nielsen Holdings plc
NLSN
| $9.1M | 0.02% |
428,163
-4,000
| -0.9% | -$88.3K |
|
539
Dell
DELL
$262B
| $9.08M | 0.02% |
+345,275
| New | +$9.15M |
|
540
Kosmos Energy
KOS
$1.6B
| $9.05M | 0.02% |
1,450,000
+450,000
| +45% | +$2.76M |
|
541
Integra LifeSciences
IART
$1.29B
| $9.01M | 0.02% |
150,000
-150,000
| -50% | -$8.94M |
|
542
iShares Biotechnology ETF
IBB
$9.34B
| $8.96M | 0.02% |
+90,000
| New | +$9.42M |
|
543
ServiceNow
NOW
$115B
| $8.88M | 0.02% |
175,000
-50,000
| -22% | -$2.72M |
|
544
Zions Bancorporation
ZION
$10.2B
| $8.85M | 0.02% |
198,886
-202,000
| -50% | -$8.73M |
|
545
LKQ Corp
LKQ
$5.68B
| $8.83M | 0.02% |
280,800
-103,500
| -27% | -$2.83M |
|
546
Flowserve
FLS
$9.71B
| $8.83M | 0.02% |
188,953
+21,691
| +13% | +$1.02M |
|
547
Grocery Outlet
GO
$909M
| $8.76M | 0.02% |
252,475
-97,525
| -28% | -$3.7M |
|
|
ARNA
548
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $8.7M | 0.02% |
190,000
| – | – |
|
549
NetApp
NTAP
$35B
| $8.56M | 0.02% |
163,000
-72,700
| -31% | -$3.9M |
|
550
Datadog
DDOG
$95.4B
| $8.48M | 0.02% |
+250,000
| New | +$8.69M |
|
Similar funds
Adage Capital Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Adage Capital Partners held 791 positions worth $40.7B, up 1.4% from $40.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Adage Capital Partners's Q3 2019 filing shows 88 new, 233 increased, 320 reduced and 78 closed positions. Its largest new stake was Kimberly-Clark: 1,083,253 shares worth $154M. The largest sale was Anadarko Petroleum, an estimated $781M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Adage Capital Partners's largest Q3 2019 buy was Kimberly-Clark: 1,083,253 shares worth $154M.
- Adage Capital Partners added most to Allergan plc in Q3 2019, an estimated $977M increase.
- Adage Capital Partners's biggest Q3 2019 reduction was Costco, cutting an estimated $133M.
- Adage Capital Partners fully exited Anadarko Petroleum in Q3 2019, selling an estimated $781M.
- Adage Capital Partners's ten largest holdings make up 20% of its $40.7B portfolio in Q3 2019.
- Adage Capital Partners opened 88 new positions and closed 78 in Q3 2019.
- Adage Capital Partners's portfolio value rose 1.4% quarter-over-quarter to $40.7B.
Based on Adage Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.